Results 211 to 220 of about 236,526 (353)

Gadofullerene inhibits the degradation of apolipoprotein B100 and boosts triglyceride transport for reversing hepatic steatosis [PDF]

, 2020
Chen Zhou, Mingming Zhen, Meilan Yu, Xue Li, Tong Yu, Jingchao Liu, Wang Jia, Shuai Liu, Lei Li, Jie Li, Zihao Sun, Zhongpu Zhao, Xinyao Wang, Xiaoyan Zhang, Chunru Wang, Chunli Bai   +15 more
openalex   +1 more source

Quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (NLV) and its standard deviation with different ROIs in patients with metabolic-associated fatty liver disease: a pilot study [PDF]

, 2021
Yanan Zhao, Chao Zhang, Shaoyan Xu, Hui Zhang, Shumei Wei, Pengfei Huang, Lufei Zhang, Yik Ning Wong, Wen Xu, Pintong Huang   +9 more
openalex   +1 more source

Molecular mediators of hepatic steatosis and liver injury.

Journal of Clinical Investigation, 2004
J. Browning, J. Horton
semanticscholar   +1 more source

Comprehensive Review on the Occurrence of Aflatoxin M1 in Milk, Prevalent Health Issues Associated With It, and Innovative Strategies for Mitigation of Aflatoxin M1 in Processed Milk

Food Safety and Health, EarlyView.
Aflatoxins, carcinogenic compounds in milk; reduction strategies such as thermal deactivation, UV light exposure, ionizing radiation, and solvent extraction. ABSTRACT Aflatoxins (AFs) are known to be cancer causing substances recognized within milk along with the milk goods.
Akshay Ramani, Tanmay Hazra, Anamika Das, Subhadip Manik, Ayon Tarafdar, Swarnima Dey, Umesh Singh   +6 more
wiley   +1 more source

Non-Invasive Assessment of Hepatic Steatosis in Patients with NAFLD Using Controlled Attenuation Parameter and 1H-MR Spectroscopy

, 2014
Thomas Karlas, David Petroff, Nikita Garnov, Stephan Böhm, H Tenckhoff, Christian Wittekind, Manfred Wiese, Ingolf Schiefke, Nicolas Linder, Alexander Schaudinn, Harald Busse, Thomas Kahn, Joachim Mössner, Thomas Berg, Michael Tröltzsch, Volker Keim, Johannes Wiegand   +16 more
openalex   +2 more sources

Establishment and characterization of an iPSC line from a 35 years old high grade patient with nonalcoholic fatty liver disease (30–40% steatosis) with homozygous wildtype PNPLA3 genotype

, 2018
Nina Graffmann, Martina Bohndorf, Audrey Ncube, Marie-Ann Kawala, Wasco Wruck, Karl Kashofer, Kurt Zatloukal, James Adjaye   +7 more
openalex   +1 more source

Probiotic Bifidobacterium Lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease [PDF]

, 2020
Yan Yan, Chunyan Liu, Shimin Zhao, Xinxu Wang, Jinling Wang, Heping Zhang, Yuzhen Wang, Guofen Zhao   +7 more
openalex   +1 more source

Differential effects of systemic immune inflammation indices on hepatic steatosis and hepatic fibrosis: evidence from NHANES 1999–2018 [PDF]

Shuyin Duan, Z. Nora Tu, Lijuan Duan, Runqi Tu   +3 more
openalex   +1 more source

Ultrasound-derived fat fraction for the noninvasive quantification of hepatic steatosis: a prospective multicenter study. [PDF]

Insights Imaging
Xue L, Zhu Y, Cheng G, Han H, He N, Chen L, Ma Z, Ge H, Jiang D, He T, Shen R, Jiang W, Sun L, Zhang J, Cai X, Xu H, Ding H.   +16 more
europepmc   +1 more source

Quantitative assessment of hepatic steatosis by ultrasound-guided attenuation parameter in patients with impaired glucose tolerance. [PDF]

Insights Imaging
Gao R, Han J, Song D, Wang P, Chen H, Shen H, Li J.   +6 more
europepmc   +1 more source